XENT
Intersect ENT, Inc
XENT
XENT
Delisted
XENT was delisted on the 12th of May, 2022.
128 hedge funds and large institutions have $678M invested in Intersect ENT, Inc in 2017 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 42 increasing their positions, 41 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 41
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
128
Holding in Top 10
1
Calls
$4.47M
Puts
$2.26M
Top Buyers
| 1 | +$26.9M | |
| 2 | +$23.9M | |
| 3 | +$20.3M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$7.6M |
| 5 |
BlackRock
New York
|
+$6.81M |
Top Sellers
| 1 | -$9.06M | |
| 2 | -$8.92M | |
| 3 | -$7.68M | |
| 4 |
Morgan Stanley
New York
|
-$6.64M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$5.13M |